68GaNOTA-Anti-MMR-VHH2

DRUG3 trials

Sponsors

Universitair Ziekenhuis Brussel

Conditions

Atherosclerosis of ArteryBreast CancerCancerCardiac SarcoidosisCarotid StenosisHLHHodgkin Lymphoma, AdultMalignant Solid Tumor

Phase 1

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

TerminatedNCT04168528

Universitair Ziekenhuis BrusselBreast Cancer, Malignant Solid Tumor, Melanoma (Skin)

Start: 2019-11-05End: 2024-12-04Updated: 2026-06-01

Phase 2

Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

TerminatedNCT04758650

Universitair Ziekenhuis BrusselAtherosclerosis of Artery, Cancer, Cardiac Sarcoidosis +6

Start: 2021-01-26End: 2025-01-08Updated: 2026-06-01

Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients

RecruitingNCT05933239

Universitair Ziekenhuis BrusselNon-small Cell Lung Cancer

Start: 2023-03-30End: 2027-04-01Target: 20Updated: 2026-06-01